Abnormal modulation of cholinergic neurotransmission by endomorphin 1 and endomorphin 2 in isolated bronchus of type 1 diabetic rats

Peptides

Volumn 27, Issue 11, 2006, Pages 2770-2777

  Yu, Ye ^a   Wang, Xiang ^a   Cui, Yun ^a   Fan, Ying zhe ^a   Liu, Jing ^a,b   Wang, Rui ^a  

^a LANZHOU UNIVERSITY   (China)

^b GANSU PROVINCIAL HOSPITAL   (China)

Author keywords

Cholinergic bronchoconstriction; Electrical field stimulation; Endomorphin 1; Endomorphin 2; Type 1 diabetic rats

Indexed keywords

ACETYLCHOLINE; ENDOMORPHIN 1; ENDOMORPHIN 2; NALOXONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATTENUATION; BRONCHOSPASM; CHOLINERGIC SYSTEM; CONCENTRATION RESPONSE; CONTROLLED STUDY; ELECTROSTIMULATION; IN VITRO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; SYNAPTIC TRANSMISSION;

ACETYLCHOLINE; ANALGESICS, OPIOID; ANIMALS; BRONCHI; BRONCHOCONSTRICTION; DIABETES MELLITUS, TYPE 1; ELECTRIC STIMULATION; MALE; OLIGOPEPTIDES; RATS; RATS, WISTAR; SYNAPTIC TRANSMISSION;

EID: 33750067708     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2006.06.002     Document Type: Article

References (47)

1. Agadjanov M.I., Vartanian G.S., Tadevosyan Y.V., Batikyan T.B., and Agadjanova E.M. Possible role of the phosphoinositide pathway for signal transduction in changes in the sensitivity of delta-opiate receptors during diabetes mellitus. Bull Exp Biol Med 137 (2004) 147-149
2. Aguayo S.M. Pulmonary neuroendocrine cells in tobacco-related lung diseases. Anat Rec 236 (1993) 122-127
3. Basso M., Risse P.A., Naline E., Calo G., Guerrini R., Regoli D., et al. Nociceptin/orphanin FQ inhibits electrically induced contractions of the human bronchus via NOP receptor activation. Peptides 26 (2005) 1492-1496
4. Belvisi M.G., Stretton C.D., Verleden G.M., Ledingham S.J., Yacoub M.H., and Barnes P.J. Inhibition of cholinergic neurotransmission in human airways by opioids. J Appl Physiol 72 (1992) 1096-1100
5. 3H]U-69,593 to airway and pulmonary tissues of normal and sensitized rats. Peptides 18 (1997) 1603-1608
6. Brichant J.-F., Warner D.O., Gunst S.J., and Rehder K. Muscarinic receptor subtypes in canine trachea. Am J Physiol 258 (1990) L349-L354
7. Champion H.C., Zadina J.E., Kastin A.J., Hackler L., Ge L.-J., and Kadowitz P.J. Endomorphin 1 and 2, endogenous ligands for the μ-opioid receptor, decrease cardiac output, and total peripheral resistance in the rat. Peptides 18 (1997) 1393-1397
8. Champion H.C., Zadina J.E., Kastin A.J., and Kadowitz P.J. Endomorphin 1 and 2 have vasodepressor activity in the anesthetized mouse. Peptides 19 (1998) 925-929
9. Chen S.R., and Pan H.L. Antinociceptive effect of morphine, but not mu opioid receptor number, is attenuated in the spinal cord of diabetic rats. Anesthesiology 99 (2003) 1409-1414
10. Drolet G., Dumont E.C., Gosselin I., Kinkead R., Laforest S., and Trottier J.F. Role of endogenous opioid system in the regulation of the stress response. Prog Neuropsychopharmacol Biol Psychiatry 25 (2001) 729-741
11. El Honsali I., Benjelloun H., Coghlan C.L., and Benomar M. Autonomic profile and cardiovascular symptoms. Ann Cardiol Angeiol (Paris) 53 (2004) 137-143
12. Fallucca F., Tonnarini G., Di Biase N., D'Allessandro M., and Negri M. Plasma met-enkephalin levels in diabetic patients: influence of autonomic neuropathy. Metabolism 45 (1996) 1065-1068
13. Fischer A., and Undem B.J. Naloxone blocks endomorphin-1 but not endomorphin-2 induced inhibition of tachykinergic contractions of guinea-pig isolated bronchus. Br J Pharmacol 127 (1999) 605-608
14. Frossard N., and Barnes P.J. Mu-Opioid receptors modulate non-cholinergic constrictor nerve in guinea-pig airways. Eur J Pharmacol 141 (1987) 519-522
15. Groneberg D.A., and Fischer A. Endogenous opioids as mediators of asthma. Pulm Pharmacol Ther 14 (2001) 383-389
16. Kamei J., Kawashima N., and Kasuya Y. Paradoxical analgesia produced by naloxone in diabetic mice is attributable to supersensitivity of δ opioid receptor. Brain Res 592 (1992) 101-105
17. Kamei J., Kawashima N., and Kasuya Y. Role of spleen or spleen products in the deficiency in morphine-induced analgesia in diabetic mice. Brain Res 576 (1992) 139-142
18. Kamei J., Ohhashi Y., Aoki T., Kawashima N., and Kasuya Y. Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by δ opioid agonists, but not by μ and k opioid agonists. Brain Res 571 (1992) 199-203
19. Kamei J., Zushida K., Ohsawa M., and Nagase H. The antinociceptive effects of endomorphin-1 and endomorphin-2 in diabetic mice. Eur J Pharmacol 391 (2000) 91-96
20. Karci A., Tasdogen A., Erkin Y., Aktas G., and Elar Z. The analgesic effect of morphine on postoperative pain in diabetic patients. Acta Anaesthesiol Scand 48 (2004) 619-624
21. Kuntscherova J., and Vlk J. Influence of alloxan diabetes on acetylcholine synthesis in tissues of the albino rat. Physiol Biochemoslov 19 (1970) 431-434
22. Kuo H.P., Rohde J.A., Barnes P.J., and Rogers D.F. Differential inhibitory effects of opioids on cigarette smoke, capsaicin, and electrically-induced goblet cell secretion in guinea-pig. Br J Pharmacol 105 (1992) 361-366
23. Larsen G.L., Fame T.M., Renz H., Loader J.E., Graves J., Hall M., et al. Increased acetylcholine release in tracheas from allergen-exposed IgE-immune mice. Am J Physiol 266 (1994) 263-270
24. Liao D., Cai J., Brancati F.L., Folsom A., Barnes R.W., Tyroler H.A., et al. Association of vagal tone with serum insulin, glucose, and diabetes mellitus. The ARIC Study. Diabetes Res Clin Pract 30 (1995) 211-221
25. Liu J., Yu Y., Fan Y.Z., Chang H., Liu H.M., Cui Y., et al. Cardiovascular effects of endomorphins in alloxan-induced diabetic rats. Peptides 26 (2005) 607-614
26. McLay R.N., Pan W., and Kastin A.J. Effects of peptides on animal and human behavior: a review of studies published in the first twenty years of the journal Peptides. Peptides 22 (2001) 2181-2255
27. Misawa M., Sato J., Furukawa Y., Chiba Y., and Hosokawa T. Abnormal modulation of cholinergic neurotransmission by opioid in hyperresponsive bronchus of rats. Gen Pharmacol 27 (1996) 441-444
28. Neidle A., Manigault I., and Wajda I.J. Distribution of opiate-like substances in rat tissues. Neurochem Res 4 (1979) 399-410
29. Ohsawa M., Mizoguchi H., Narita M., Kamei J., Nagase H., and Tseng L.F. Effects of a mu-opioid receptor agonist on G-protein activation in streptozotocin-induced diabetic mice. Eur J Pharmacol 401 (2000) 55-58
30. Oida E., Kannagi T., Moritani T., and Yamori Y. Diabetic alteration of cardiac vago-sympathetic modulation assessed with tone-entropy analysis. Acta Physiol Scand 165 (1999) 129-134
31. Patel H.J., Barnes P.J., Takahashi T., Tadjkarimi S., Yacoub M.H., and Belvisi M.G. Evidence for prejunctional muscarinic autoreceptors in human and guinea pig trachea. Am J Resp Crit Care Med 152 (1995) 872-878
32. Patel H.J., Venkatesan P., Halfpenny J., Yacoub M.H., Fox A., Barnes P.J., et al. Modulation of acetylcholine release from parasympathetic nerves innervating guinea-pig and human trachea by endomorphin-1 and -2. Eur J Pharmacol 374 (1999) 21-24
33. Russell J.A., and Simons E.J. Modulation of cholinergic neurotransmission in airway by enkephalin. J Appl Physiol 58 (1985) 853-858
34. Shimosegawa T., Foda H.D., and Said S.I. Immunohistochemical demonstration of enkephalin-containing nerve fibers in guinea pig and rat lung. Am Rev Respir Dis 40 (1989) 441-448
35. Sibinga N.E.S., and Goldstein A. Opioid peptides and opioid receptors in cells of the immune system. Annu Rev Immunol 6 (1988) 219-249
36. Stein C. The control of pain in peripheral tissue by opioids. New Engl J Med 332 (1995) 1685-1690
37. Storr M., Hahn A., Gaffal E., Saur D., and Allescher H.D. Effects of endomorphin-1 and -2 on mu-opioid receptors in myenteric neurons and in the peristaltic reflex in rat small intestine. Clin Exp Pharmacol Physiol 29 (2002) 428-434
38. Szkudelski T. The mechanism of alloxan and steptozotocin action in B cell of the rat pancreas. Physiol Res 50 (2001) 536-546
39. 5]enkephalin-induced peripheral antinociception in diabetic rats: the role of the l-arginine/nitric oxide/cyclic guanosine monophosphate pathway. Anesth Analg 98 (2004) 185-192
40. Tseng L.F., Narita M., Suganuma C., Mizoguchi H., Ohsawa M., Nagase H., et al. Differential antinociceptive effects of endomorphin-1 and endomorphin-2 in the mouse. J Pharmacol Exp Ther 292 (2000) 576-583
41. Tomlinson D.R., and Yusof A.P.M. On the structural and functional integrity of autonomic nerves in rats with long-term diabetes mellitus induced by alloxan. Br J Pharmacol 74 (1981) p. 84
42. Wanke T., Lahrmann H., Auinger M., Merkle M., Formanek D., Ogris E., et al. Endogenous opioid system during inspiratory loading in patients with type I diabetes. Am Rev Respir Dis 148 (1993) 1335-1340
43. Yokatani K., and Osumi Y. Involvement of mu-receptor in endogenous opioid peptide-mediated inhibition of acetylcholine release from the rat stomach. Jpn J Pharmacol 78 (1998) 93-95
44. Yu Y., Cui Y., Wang X., Fan Y.Z., Liu J., Yan X., and Wang R. Endomorphin 1 and endomorphin 2, endogenous potent inhibitors of electrical field stimulation (EFS)-induced cholinergic contractions of rat isolated bronchus. Peptides 27 (2006) 1846-1851
45. Yu Y., Wang C.L., Cui Y., Fan Y.Z., Liu J., Shao X., et al. C-terminal amide to alcohol conversion changes the cardiovascular effects of endomorphins in anesthetized rats. Peptides 27 (2006) 136-143
46. Zadina J.E., Hackler L., Ge L.J., and Kastin A.J. A potent and selective endogenous agonist for the mu-opiate receptor. Nature 386 (1997) 499-502
47. Zappi L., Song P., Nicosia S., Nicosia F., and Rehder K. Inhibition of airway constriction by opioids is different down the isolated bovine airway. Anesthesiology 86 (1997) 1334-1341